SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias sharp selloff is being tied to concerns that the midterm results and calls for tighter data-center oversight could slow AI infrastructure spending and chip demand, amid a broader semiconductor rout. Traders are divided between viewing the drop as an overreaction and buying opportunity and worrying that weaker capex growth and financing risks could signal an AI-trade slowdown; no broad halt to data-center construction is established.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavaxs quarterly results and raised 2026 revenue outlook, supported by a Sanofi milestone, dominate discussion. Traders welcome the earnings improvement and licensing strategy, while skeptics argue milestone income has yet to prove durable sales or replace the need for new deals and pipeline data; the stock fell despite the upbeat report.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is under pressure as traders worry that election-driven opposition to data centers could slow AI infrastructure spending, while broader concerns about capex returns and financing weigh on semiconductor valuations. The community is split between calling the selloff an overreaction and viewing it as a deeper unwind of the AI trade.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOIs shares sold off sharply despite a quarterly earnings beat, as its next-quarter revenue outlook came in below expectations and management said U.S. capacity expansion would take longer amid power and construction delays. Bulls point to the hyperscaler agreement and continued demand for data-center optics, while bears focus on execution, margins, and uncertainty around AI infrastructure spending.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris strong quarterly results, rapid Recorlev growth and raised revenue outlookincluding a faster path toward $1 billion in annual Recorlev salesare driving the rally. Traders are broadly bullish on the growth story, while some also speculate about a potential buyout, which remains unconfirmed.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Roots quarterly results sparked a sharp selloff, with traders focusing on declining premiums and flat-to-lower policies in force despite positive earnings and improved underwriting. Bulls point to profitability and share buybacks as support, while bears argue stalled growth weakens the investment case.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins stronger-than-expected Q3 results, upbeat outlook and improved AI-driven ad model are driving a sharp post-earnings rally, with traders also pointing to the expanded buyback. Many celebrate the rebound and resilience amid a broader market selloff, while others warn that the rapid run could invite profit-taking and question how durable the growth is.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings Q3 results missed expectations and the company cut its full-year outlook, triggering a sharp selloff as traders focused on rising costs and heavy investment in its Predictions business. The reaction is largely bearish, with criticism of management and fears that Kalshi and other prediction-market rivals are taking share, while some investors argue the spending is intended to build growth.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.21896617 USD and is down -6.75 over the last 24 hours. It is currently trading on 1894 active market(s) with $2,821,731,810.20 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

A broad crypto selloff, with traders linking added uncertainty to the Binance hack and market-wide liquidations, is weighing on XRP. The community is split between treating the drop as a buying opportunity and fearing further losses, with midterm-election and Clarity Act concerns also adding to the debate.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas preliminary warning that DefenCaths reimbursement could decline through 2027 has fueled selling and concern about the drugs revenue outlook. Traders debate whether that signals a lasting commercial headwind or is uncertain early modeling, while some point to REZZAYOs priority review as a potential offset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can MPC's Gulf Coast Focus Fuel Stronger Future Refining Returns?

Marathon Petroleum's $4.2B asset sale sets the stage for Gulf Coast investments aimed at boosting diesel output, crude throughput and premium gasoline exports.

CVR Energy Q3 2026 Earnings Call Transcript

CVR Energy (NYSE:CVI) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

CVR Energy Announces Proposed Offering of Common Stock

CVR Energy, Inc. (the Company or CVR Energy) (NYSE: CVI) today announced the commencement of an underwritten public offering of $750 million of shares of its common stock (the Offering). The Company is offering $500 million of shares of its common stock and IEP Energy Holding LLC (the Selling...

Marathon Petroleum, MPLX To Sell Refineries, Midstream Assets To CVR Energy For $4.2 Bln

(RTTNews) - Refiner Marathon Petroleum Corp. (MPC) and midstream operator MPLX LP (MPLX) announced on Tuesday that they have agreed to sell two refineries and related midstream assets in Minnesota and North Dakota to CVR Energy Inc. (CVI) for $4.2 billion, plus inventory value an...

CVR Energy (CVI) Q3 Earnings and Revenues Beat Estimates

CVR (CVI) delivered earnings and revenue surprises of +29.45% and +50.60%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

CVR Energy Reports Third Quarter 2026 Results

CVR Energy, Inc. (CVR Energy or the Company) (NYSE: CVI) today announced its third quarter 2026 results including a net income attributable to CVR Energy stockholders of $570 million, or $5.67 per diluted share, and an adjusted earnings per diluted share of $4.00, compared to net income...

Marathon Petroleum Corp to Divest Minnesota and North Dakota Refineries & MPLX LP to Divest Related Midstream Assets

Marathon Petroleum Corp to Divest Minnesota and North Dakota Refineries & MPLX LP to Divest Related Midstream Assets Marathon Petroleum Corp to Divest Minnesota and North Dakota Refineries & MPLX LP to Divest Related Midstream AssetsPR NewswireFINDLAY, Ohio, Nov. 3, 2026 FINDLAY, Ohio, Nov. 3, 2026...

CVR Energy Announces Transformative Transaction to Acquire 2 Refineries and Marketing Platform From Marathon Petroleum

CVR Energy, Inc. (NYSE: CVI) (CVR Energy) today announced that it has entered into a definitive agreement with subsidiaries of Marathon Petroleum Corporation (NYSE: MPC) (Marathon) under which CVR Energy would acquire (the Acquisition) Marathons St. Paul Park, Minnesota and Mandan, North Dakota...

Is Paramount Resources (PRMRF) Stock Outpacing Its Oils-Energy Peers This Year?

Here is how Paramount Resources (PRMRF) and CVR Energy (CVI) have performed compared to their sector so far this year.

Are Options Traders Betting on a Big Move in CVR Energy Stock?

Investors need to pay close attention to CVI stock based on the movements in the options market lately.

$CVI Q3 &#39;26 Earnings Results &amp; Recap

CVR Energy estimates 2026 capital expenditures of $220M to $240M, including $114M to $123M for Petroleum and $95M to $104M for Nitrogen Fertilizer.

Stocktwits

CVR Energy Inc

 Q3 '26 Earnings Results & Recap

CVR Energy estimates 2026 capital expenditures of $220M to $240M, including $114M to $123M for Petroleum and $95M to $104M for Nitrogen Fertilizer.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

CVR Energy estimates 2026 capital expenditures of $220M to $240M, including $114M to $123M for Petroleum and $95M to $104M for Nitrogen Fertilizer.

CVR Energy faced fertilizer-segment losses, commodity derivative losses and RFS liability exposure; its pending $4.2B acquisition carries execution, regulatory, integration and substantial indebtedness risks.

CVR Energy's Petroleum Segment operating income rose year over year, WRC's RFS waiver reduced obligations by approximately $253M, and East Dubuque's completed ammonia expansion is expected to add approximately 5% capacity.

CVR Energy, Inc. is a holding company. The firm engages in the petroleum refining and marketing business. It operates through the following segments: Petroleum, Renewables and Nitrogen Fertilizer. The Petroleum segment refines and markets high value transportation fuels. The Renewables segment includes the operations of the renewable diesel unit. The Nitrogen Fertilizer segment markets nitrogen fertilizers primarily in the form of UAN and ammonia. The company was founded in September 1906 and is headquartered in Sugar Land, TX.

CVR Energy Stock Rises After Smaller-Than-Expected Q4 Loss: Retail Mood Brightens

Equity

Bullish Sentiment

CVR Energy (CVI) stock gained 3% in aftermarket trading on Tuesday after the company reported a smaller-than-expected fourth-quarter loss.According to Koyfin data, the company's adjusted loss was $0.13 per share during the reported quarter, while analysts, on average, expected it to post a loss of $0.62 per share.The refiner posted a net income of $28 million, or $0.28 per share, compared to $91 million, or $0.91 per share, last year.The company’s refining margin for the fourth quarter fell to $165 million, or $8.37 per total throughput barrel, from $307 million, or $15.01 per total throughput barrel, in the year-ago quarter.Global refining margins declined in the fourth quarter amid tepid fuel demand in countries such as China and the start-up of new refineries in Europe and Asia.The company’s renewable segment net loss narrowed to $3 million from $30 million in the year-ago quarter.“We commenced our planned Coffeyville turnaround early, which should position us well for the improvement in cracks we expect as summer driving season begins and capacity rationalization occurs,” CEO Dave Lamp said.In December, CVR projected total capital spending in 2025 between $165 million and $205 million.Icahn Enterprises is the majority shareholder of the refiner, which operates the Coffeyville refinery in Kansas and the Wynnewood facility in Oklahoma.Retail sentiment on Stocktwits rose higher in the ‘extremely bullish’ (93/100) territory, while retail chatter rose to ‘extremely high.’<figure class="image"><img style="aspect-ratio:805/182;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CVI_Feb_19_865f926250.JPG" alt="CVI’s Sentiment Meter and Message Volume as of 3:32 p.m. ET on Feb. 19, 2025 | Source: Stocktwits" width="805" height="182"><figcaption>CVI’s Sentiment Meter and Message Volume as of 3:32 p.m. ET on Feb. 19, 2025 | Source: Stocktwits</figcaption></figure>Over the past year, <a href="https://stocktwits.com/symbol/CVI">CVR stock</a> has gained 49.2%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/shift4-payments-stock-sinks-on-2-5-b-deal-to-buy-global-blue-but-retail-bulls-aren-t-fading/ch5rrJLRv6">Shift4 Payments Stock Sinks On $2.5B Deal To Buy Global Blue, But Retail Bulls Aren't Fading</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a stock chart on black background. | Image source: Getty Images

According to Koyfin data, the company's adjusted loss was $0.13 per share during the reported quarter, while analysts, on average, expected it to post a loss of $0.62 per share.

Icahn Enterprises, L.P.

Fundamental investor

Technical trader

A mix of both

Fundamental analysis looks at earnings, valuation, and business quality, while technical analysis focuses on chart patterns, price action, and indicators, and many investors blend the two. How do you decide what to buy: fundamentals or technicals? Vote and explain your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CVI News